You read this week’s publication New Cannabis Ventures Weekly Newsletter we publish from October 2015. We no longer send them. By mail as before but we post this and all newsletters On our website hereA number
Friends,
On Friday, the S & P Dow Jones indicators announced that five shares will join the S & P / TSX composite index, including CURALAF. Since then, Curlf has earned 0.4%, rising a lot of Tuesday, but pulling yesterday. Not surprisingly, the company has a success in a press release on Monday morning, offering it to promote institutional property.
In late 2023, the Toronto Stock Exchange listed from the exchange of Canadian securities, where the market was originally entered. Terascend was the first to move to TSX, and the release moved to CAADA Conafe’s Curalaf transfer to TSX and which took place in 2023.
In two years or the way this MSOS has made their steps, no other MSOS followed. Considering that no other MSOS migrated to sleep from CSE because it did the same in the last 2023, probably doesn’t make it mean to do it. Of course, CSE has some challenges, but the bigger problem is that they are American companies. Where commercial problems are in the United States and not in Canada. Nothing against Canada but TSX list doesn’t actually change things. By the end of 2022 I called OTC as a Main potential catalystA number
In this newsletter of October 2023, I called it a waste of time To modernize TSX for American Cannabis. Looking at the price of prices, as this newsletter was published for the first degree and one of the second level, one of the nine MSOS gathered, and the rest decreased.
Readers should remember that the hemp section has decreased a lot in this moment, the NCV Global Cannabis stock index decreased by 16.6% to 6.90. The American Cannabis stock index decreased by 21.8%, and MSOS fell 34.0%. The average return of these 9 largest MSOS has even worse, but it greatly affects a murder, which has been suspended in Canada, but continues to trade on OTC.
Looking back, I would not conclude that trade exchange in Canada is generally important. One of the TSX listed shares did a little better than his peers, and one was bad. Much more than the Canadian listing drives drives the stock. I was shocked in June, when I was doing the quarterly redistribution of the Cannabis World Stock Index that the crankle was out due to insufficient trade. Only 3 MSOS qualified, resourceful and GTI and also glass home brands that trade in Canada (72.7% are increased from 10/30). In the past month, the volume of Curaleaf trade in Canada was 1,14 million shares, which is less than it trades on OTC. Perascend is 463k shares per year in the previous month, which is much less than an OTC average in one day 1 million shares. Looking at the other MSOS that trades on various exchanges in Canada, they have been a higher trade volume in OTC.
Kuralef and the tribe were so proud to discharge TSX in Canada two years ago, but it doesn’t really matter. How I used to say for several years now, what is 280e floor and OTC? I hope that 280 ends soon, but even if the hemp has resumed, there is no need to change the NASDAQ or NYSE about American hemp companies. I hope to change too.
Frankly,
Alan
New hemp enterprises publish medicine articles, as well as exclusive news. Here is what we published this last week.
To get real-time updates follow Alan X.com:Sharing a number and discover industry news along with supporters, the largest hemp group and entrepreneurs group ConnectionA number
Stay on top of some important communications of public companies by watching upcoming Cannabis Investor Calendar:A number
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
Michigan hemp sales for the month of December increased from a year ago as they rose 3.8% sequentially, which was +0.5% on a daily basis. At $269.7 million, sales increased by 1.6 percent compared to last year.
The Michigan Cannabis Regulatory Agency breaks down sales by medical and adult use, with medical sales down 50.2% year-over-year to $0.4 million, up 10.8% sequentially, and adult-use sales up 1.7% year-over-year to $269.3 million, up 3.8% sequentially.
The state breaks down sales by category and provides pricing details by category for both medical and adult;
For adultsMedical
As supply continues to expand, prices for adult flowers have plummeted. The average price of $932 a pound in December fell 2.6 percent sequentially to a new record low and fell 15.9 percent from a year earlier.
Michigan hemp sales are expected to grow 82.1% to $1.79 billion in 2021, 27.9% to $2.29 billion in 2022, and 33.3% to $3.06 billion in 2023. forward as supply becomes more accessible and distribution expands.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Hemp stocks, as measured by the Global Hemp Stock Index, were quite volatile in 2024 and then again in 2025 as well. The index fell 7.5% in December last year to close 15.2% lower for the year, and it was also a poor start to 2025. It hit a new all-time high of 4.97 on the last day of March, before falling back in early April. The index gained 11.5% in April, but ended the second quarter from there, closing at 5.02. Q3 was strong with increases in July and August, and September, which started with a pullback, ended with another increase before pulling back on the last day. The index ended September down just a little, before falling in October and even lower in November. It rose sharply in December, rising 8.4% to 6.59. While stocks rose, 13 of the index’s 28 names declined for the month.
After collapsing 21.8% in late 2024 to 6.88 in Q4, the index fell heavily in Q1 and then marginally in Q2. The global hemp stock index, which now has 28 members, fell 27% year-to-date in June. After a 53.0 percent rally in the third quarter, the index increased by 11.6 percent compared to last year. It fell 14.2% in the 4th quarter and was down 4.2% for the full year.
Since its peak in February 2021, the global hemp stock index is down 92.9% from a closing high of 92.48.
The 3 strongest names in December, each an MSO, are all up more than 58%;
Each of these stocks were significantly up year-over-year, and Q4 earnings were positive for Trulieve.
December’s 3 weakest names are all down more than 8%;
All of these stocks were down year-over-year, and Q4 was brutal for each.
The index has been recalculated as of the close of 12/31/31 and is based on data as of 12/23/23. For Q1, the index will have 27 names, down from 28 names, with three removals and two additions. AFCG, LIEN and SHFS are excluded from the index. Akanda (AKAN) and cbdMD (YCBD) are rejoining the index.
We will summarize the performance of the index again in a month. In April, we historically combined the two articles, and we update here the other indexes that New Cannabis Ventures continues to maintain: the American Cannabis Operator Index, the Ancillary Cannabis Index, and the Canadian Cannabis LP Index.
American Hemp Operator Index
ACOI rallied in December, rising 43.7% to 13.18. It rose 123.6% to 12.99 in the third quarter and ended the year up 57.7% year to date from 8.36. The large AdvisorShares Pure US Cannabis ETF ( MSOS ) was a big laggard, up 23.9%.
December’s strongest stock was Trulieve, which gained 61.2%. The weakest, Curaleaf (OTC: CURLF ) (TSX: CURA ), rose 10.4%.
In January, the index will have eleven members, with the additions of Ascend Wellness (OTC: AAWH ), Grown Rogue (GRUSF ), and Vireo Health (OTC: VREOF ).
Auxiliary cannabis index
Ancillary commodities rose 2.4% in December as the index reached 11.09. The index, which rose 14.5% to 12.72 in the third quarter, fell 12.8% in the fourth quarter. It decreased by 19.5% from 13.77 in 2025.
The strongest performing stock in December was NewLake Capital (OTC: NLCP ), which rose 24.1%. The weakest, Chicago Atlantic Real Estate Finance (NASDAQ: REFI ), fell 3.9%.
In January, the index will have the same eight members and two that are returning: iPower (NASDAQ: IPW ) and Chicago Atlantic BDC (NASDAQ: LIEN ).
Canadian Hemp LP Index
Canadian LPs rose 5.4% in December as the index fell to 59.01. The index, which increased by 78.4% in the third quarter, reaching 73.56. Declined 19.8% in Q4, but rose 17.8% in 2025 from 50.11.
The strongest Canadian LP in December was MTL Cannabis (CSE: MTL ), which jumped 62.5% after receiving a buy order. The weakest performer was Aurora Cannabis, down 10.3%.
In January, the index will have the same thirteen members.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Michigan hemp sales for the month of november down from a year ago as they were down 3.0% sequentially, which was +0.2% on a daily basis. Sales at $259.7 million decreased by 6.0 percent compared to last year.
The Michigan Cannabis Regulatory Agency breaks down sales by medical and adult use, where medical sales fell 58.1% year over year to $0.4 million, down 9.7% sequentially, and adult use sales fell 5.9% year-over-year to $250.9 million, down 3.0% sequentially.
The state breaks down sales by category and provides pricing details by category for both medical and adult;
For Adults – Use
Medical
As supply continues to expand, prices for adult flowers have plummeted. The average price of $957 a pound in October fell 3.4% sequentially to a new record low and fell 16.8% from a year ago.
Michigan hemp sales will grow 82.1% to $1.79 billion in 2021, 27.9% to $2.29 billion in 2022, and 33.3% to $3.06 billion in 2023. In 2024, they increased by 7.6% to $3.29 billion. expand further as supply becomes more available and as distribution expands.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Michigan hemp sales will grow 82.1% to $1.79 billion in 2021, 27.9% to $2.29 billion in 2022, and 33.3% to $3.06 billion in 2023. In 2024, they increased by 7.6% to $3.29 billion. expand further as supply becomes more available and as distribution expands.
